Log in

SEOM clinical guidelines for the treatment of small-cell lung cancer

  • Educational Series
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

References

  1. Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the SEER database. J Clin Oncol 24:4539–4544

    Article  PubMed  Google Scholar 

  2. Mascaux C, Paesmans M, Berghmans et al (2000) A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and metaanalysis. Lung Cancer 30:23–36

    Article  CAS  PubMed  Google Scholar 

  3. Sundstrom S, Bremnes RM, Kaasa S (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672

    Article  CAS  PubMed  Google Scholar 

  4. Amarasena I, Walters JA, Wood-Baker R, Fong K (2008) Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev (4):CD006849

    PubMed  Google Scholar 

  5. Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618–1624

    Article  CAS  PubMed  Google Scholar 

  6. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895

    CAS  PubMed  Google Scholar 

  7. Turrisi AT, Kim K, Blum R et al (1999) Twicedaily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271

    Article  CAS  PubMed  Google Scholar 

  8. De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al (2006) Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24:1057–1063

    Article  PubMed  Google Scholar 

  9. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484

    Article  CAS  PubMed  Google Scholar 

  10. Artal-Cortés A, Gómez-Codina J, González-Larriba JL et al (2004) Prospective randomized trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small cell lung cancer. Clin Lung Cancer 5:360–365

    Article  Google Scholar 

  11. Medical Research Council Lung Cancer Working Party (1996) Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Lancet 348:563–566

    Article  Google Scholar 

  12. Dómine M, Casado V, Rubio G et al (2008) New drugs for small cell lung cancer. Cancer Chemother Rev 3:212–222

    Google Scholar 

  13. Hanna N, Bunn PA Jr, Langer C et al (2006) Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038–2043

    Article  CAS  PubMed  Google Scholar 

  14. Eckardt JR, Von Pawel J, Papai Z et al (2006) Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapynaive patients with extensive-disease small-cell lung cancer. J Clin Oncol 24:2044–2051

    Article  CAS  PubMed  Google Scholar 

  15. Jeremic B, Shibamoto Y, Nikolic N et al (1999) Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 17:2092–2099

    CAS  PubMed  Google Scholar 

  16. Inoue A, Sugawara S, Yamazaki K et al (2008) Randomized, phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol 26:5401–5406

    Article  CAS  PubMed  Google Scholar 

  17. Slotman B, Faivre-Finn C, Kramer G et al (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664–672

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

Supported by an unrestricted educational grant from MSD Oncology

Clinical Guideline Working Group on behalf of the Spanish Society of Medical Oncology (SEOM)

Ramón Colomer, Emilio Alba, Antonio Llombart, Miguel Martín, Álvaro Rodríguez, Javier Salvador, Joan Albanell, Antonio González, Dolores Isla, María Lomas, César A. Rodríguez, José Manuel Trigo

Rights and permissions

Reprints and permissions

About this article

Cite this article

Artal Cortés, Á., Dómine Gómez, M., Font Pous, A. et al. SEOM clinical guidelines for the treatment of small-cell lung cancer. Clin Transl Oncol 12, 27–31 (2010). https://doi.org/10.1007/s12094-010-0463-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-010-0463-2

Keywords

Navigation